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The Risk Adjustment Reform Act of 2001 mandates that a health-status-based risk adjustment 
mechanism has to be implemented in Germany’s Statutory Health Insurance system by 
January 1, 2007. German parliament decided this as with the existing demographic risk 
adjustment model, that means there is cream skimming and sickness funds hesitate to engage 
in managing care for the chronical ill. 
Four approaches were used to test the feasibility of incorporating use of diagnosis as a proxy 
measure for health status in a German risk adjustment formula. The first two models used 
standard demographic and socio-demographic variables. The other two models are 
separately incorporating a simple binary indicator for hospitilization and Hierarchical 
Coexisting Conditions (HCCs: DxCG
® Risk Adjustment Software Release 6.1) using inpatient 
diagnosis. 
Age and gender grouping accounted for 3.2% of the variation in total expenditures for 
concurrent as well as  prospective models. The current German risk adjusters age, sex, and 
invalidity status account for 5.1% and 4.5% of the variance in the concurrent and prospective 
models respectively. There are substantial increases in explanatory power, however, when 
HCCs are added. Age, gender, invalidity status and HCC covariates explain about 37% of the 
variations of the total expenditures in a concurrent model and roughly 12% of the variations 
of total expenditures in a prospective model. For high-risk (cost) groups, substantial under-
prediction remains; conversely, for the low-risk group, represented by enrolees who did not 
show any health care expense in the base year, all of the models over-predict expenditure.  
 
Key words: Risk Adjustment, HCCs, Germany 
  31.  Introduction 
In 1993, Germany adopted new Statutory Health Insurance (SHI) legislation to grant all 
enrolees free choice of health insurer and promote competition among sickness funds. The 
motive behind this move from an originally captive employment-based social insurance 
system to a system of a competitive insurance market has been to increase cost responsibility 
of sickness funds and to secure improvements in terms of efficiency, quality, innovation, and 
responsiveness to consumer preferences. 
About 90% of the German population are offered nearly universal access to health care under 
largely compulsory and non-profit insurance schemes – the sickness funds –, which, together, 
make up the SHI. Individuals who are not insured through SHI, mostly civil servants and the 
self-employed (about 10 per cent or 8.5 million in 2003) carry commercial insurance offered 
by private health insurance companies. Health care under SHI is based on the notion of 
solidarity and financed through earnings-related contributions by individuals, with matching 
employer payments; the insurance cover automatically includes all non-earning dependents 
(without own income).  
The sickness fund market is highly regulated. Open enrolment (under which a sickness fund 
must, in principle, accept all applicants) and community-rating are required. Benefits under 
SHI are largely standardised and portable. The package is comprehensive and encompasses 
preventive, diagnostic, therapeutic and rehabilitative benefits in kind as well as in cash 
(primarily sickness benefits). This increases incentives for sickness funds to encourage 
enrolment of better health risks and discourage enrolment of worse ones, thereby competing 
on risk selection and not on price, service, quality and efficiency. Risk selection as well as 
adverse selection and other types of self-selection contributes to risk segmentation, in which 
sickness funds experience different levels of risk in the populations they cover. To help the 
sickness fund market function properly and create a “level playing field”, the 1993 legislative 
reforms also introduced a risk adjustment scheme, which on the one hand adjusts for 
differences in the income of the insured (as the base for income related contributions) and on 
the other hand adjusts for expenditure risks of the enrolee: Sickness funds pay an income 
related solidarity contribution (for the terminology see [1]) into the risk adjustment 
mechanism, and in return they receive a risk adjusted premium subsidy from that pool. 
Different approaches for grouping enrolees and predicting those groups’ health care expenses 
give rise to different risk adjustment systems. In Germany, the premium subsidy  which the 
  4risk adjustment pool pays to the sickness funds is primarily adjusted for age, sex and an 
invalidity status indicator (i.e., the drawing of disability benefits).
1 There is evidence that 
these socio-demographic factors are much too crude to reflect actual health care expenditures 
accurately. Only about 5% of the variation in SHI allowances in kind has been found to be 
explained by age, sex and disability status as risk factors [3]. Concerns about the limitations 
of the current risk adjustment system resulted in the Risk Adjustment Reform Act of 2001, 
which mandates that by 2007 the existing system of risk adjustment be replaced with one that 
takes enrolees’ health status into account. International research indeed shows risk adjustment 
models that include utilisation of health services as a proxy measure for health status –
diagnoses, procedures, and prescriptions from administrative claims data for instance – 
perform much better than systems based on demographics or socio-demographics alone
2.  
To date, there has only been limited research on risk assessment and adjustment in Germany. 
The lack of data is indeed a problem. Current legislative provisions covering privacy as well 
as other aspects, especially the tradition of self-governance for sickness funds and providers 
alike and its brassbound apologia , place constraints on the linking of data sets to trace patient 
encounters within the health system. Several countries, however, notably the US and the 
Netherlands, have had experience in developing, implementing and refining methods of risk 
assessment based on health care utilisation data to explain and predict cost variation and 
hence to set risk-adjusted capitation payments. Some of these health-based risk adjusters, 
which differ substantially in the “heritage”, logic and most common applications, have now 
been adopted by a number of US payers and the Dutch government. The practical question 
then becomes whether it is possible to use these same risk adjustment methods in Germany 
for the purpose of categorising health risks sufficiently well to mitigate the financial rewards 
and penalties of risk selection and adverse selection. 
In this paper we report on the first application and adaptation of a US system of risk 
assessment to a German sickness fund population. We sought to evaluate the performance of a 
major diagnosis-based case-mix measure, the Diagnostic Cost Group/Hierarchical Condition 
Category (DCG/HCC), in explaining variation in health care resource use in a SHI population 
of North-Eastern Germany. Specifically, we assess the explanatory power of this risk 
adjustment model in a concurrent (i.e., same-year) and prospective (next-year) framework. 
                                                 
1 The adjustment mechanism also accounts for the type of entitlement to sickness benefits, which are income-
related allowances in cash and shall not be considered in this study. For a detailed analysis of the existing risk 
adjustment mechanism in Germany see [2]. 
2 See for an overview [1] 
  51.1  DCG/HCC risk assessment method 
The Diagnostic Cost Group/Hierarchical Condition Category (DCG/HCC) system is a family 
of diagnosis-based risk profiling and assessment methods developed by Arlene Ash, Randall 
Ellis and colleagues at Boston University and Lisa Iezzoni of Harvard Medical School. The 
single-condition DCG models originally sought to predict year-2 expenditure for Medicare 
beneficiaries 65 years of age and older based on their single worst principal inpatient 
diagnosis in year 1 [4]. The classification methodology has since been refined, adapted to 
other populations, and extended to predict year-1 (concurrent modelling) as well as year-2 
(prospective modelling) expenditure on the basis of both ambulatory and inpatient diagnoses 
of year 1. Also, with the more recent multi-condition HCC models, predictions are derived 
from the full set of medical conditions present from individuals' encounters with the health 
care system, i.e., the cumulative expenditure effect of multiple conditions is captured. To limit 
the sensitivity of these models to coding idiosyncrasies and code proliferation, multiple 
interrelated ICD-9-CM diagnosis codes for common conditions are grouped and arrayed in a 
hierarchy based on expense; within each hierarchy, individuals are only assigned to the 
highest group, which stands for their worst, i.e., their most expensive diagnosis . 
We gauged the models’ relative overall performance by examining the deviation of the 
intercept and slope estimates. To characterize the health status of individuals, the 
DCG/hierarchical condition category (HCC) concurrent and prospective model, as 
implemented in DxCG
® Release 6.1 was used [5].  
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  62.  Data and Methods 
2.1  Data 
This study used administrative data files of a population of over 755,000 individuals of all 
ages who were insured with a regional sickness fund operating in North-Eastern Germany at 
any time during a period of two consecutive years, 1997 and 1998. An anonymised unique 
person identifier allowed for the linkage of data files to create one complete data set 
containing 1997 and/or 1998 socio-demographic, diagnostic and expenditure information for 
each insuree. 
Available socio-demographic information comprised the date of birth, gender, an indicator for 
the receipt of an invalidity pension, the length of entitlement to long-term care (LTC) 
insurance benefits, and the time span of enrolment per calendar year including an indicator for 
death when applicable. For the concurrent analyses of this article, all persons with any cover 
in 1997 were retained, i.e., a population of 788,130 individuals. Out of the 755,926 
individuals with any cover in 1998, a sample of 733,378 individuals had been insured with the 
same fund in 1997; this sample was retained for the prospective analyses. Partial year insurees 
in the 1997 and 1998 populations included those who died, the newborn, recent entrants, and 
those who opted out of the fund; none of them was excluded (see table 1 at the end of the 
paper).  
A claims history file for all hospitalisations ending in 1997 and 1998 respectively provided 
data on the length of stay, the principal 3- or 4-digit International Classification of Diseases, 
9
th revision (ICD-9) diagnostic code on discharge, and the charges for each episode of 
inpatient care and rehabilitation. Applying a US-American diagnosis-based risk adjustment 
model to German data necessitates a crossover of German ICD-9 to US-American ICD-9, 
Clinical Modification (ICD-9-CM) codes. This study used a crossover itemised in [1]. 
The study data files further contained an insuree's annual health care expenditure by type of 
service, including annual per-person payments for hospital care, ambulatory care (provided by 
both general practitioners and specialists), prescription drugs, dental care, ancillary services, 
durable medical equipment, and home health, as well as sickness benefits. The total annual 
expenditure per insuree was calculated by summing up individual payment amounts accross 
the different types of service during the calendar year. Spa treatment payments were not 
included in this total since they are not allowed for in Germany's risk adjustment scheme; 
neither were sickness benefits, because these benefits in cash are income-related. All 
  7expenditure data of this study is reported after co-payments for those not exempted from cost 
sharing are deducted. 
Except for annual per-person payments for ambulatory and dental care, all socio-
demographic, diagnostic, and expenditure information was derived from generally compiled 
computerized data files. Individual payment data for ambulatory and dental care were a "by-
product" of an experimental no-claims bonus arrangement effective in 1997 and 1998 that 
allowed the refund of a month worth contribution rate if an insured person had had no claims 
on curative medical services in a calendar year. Providing the sickness fund with expenditure 
information on individual services was a prerequisite for this arrangement – normally, the 
physicians’ and dentists’ self-governing bodies in charge of the reimbursement of office-
based physicians and dentists do not release any insuree-level claims data to sickness funds. 
The data were reviewed for general plausibility and validity. Where appropriate, the sickness 
fund submitting the data was contacted to verify problems and identify possible solutions. 
 
 
2.2  Methods 
Predictive performance 
Risk assessment models for study  
The following models were evaluated: a demographic model, the current socio-demographic 
model, a model incorporating a simple binary indicator for hospitalisation, and a DCG/HCC 
model.  
Demographic model: Age and gender 
Preliminary analyses for this basic age/gender model had shown that there is hardly any 
difference in the explanation of expenditure variance when using broader age clusters instead 
of 1-year age groups (from 0 to ≥90) as laid down in Germany’s current risk adjustment 
scheme. Clearly 1-year age groups make a weights matrix cumbersome to operationalise. The 
number of age/gender entries was therefore reduced to 26 age/gender groupings, 13 each for 
females and males aged 0-5, 6-13, 14-17, 18-25, 26-35, 36-45, 46-55, 56-60, 61-65, 66-70, 
71-75, 76-80 and ≥81 respectively. 
Socio-demographic model: A binary indicator for invalidity with age and gender 
Over and above age and gender, the model differentiates persons who are entitled to an 
invalidity pension from all others, thus simulating Germany's current socio-demographic risk 
  8assessment methodology. Insurees who did not draw an invalidity pension were assigned to 
one of the 26 age/gender groups described above. Recipients of an invalidity pension – 
entitlement to such a pension is possible from age 18 to 65 – were in turn assigned to 14 
age/gender groups with age groups for ≤ 35, 36-40, 41-45, 46-50, 51-55, 56-60 and 61-65 
years. For the purposes of risk assessment, invalidity status was defined as entitlement to 
invalidity benefits in any single month during the risk year (i.e., all or part of 1997 in both the 
concurrent and the prospective framework). Interaction among age/gender and invalidity is 
accounted for.  
Hospitalisation model: A binary indicator for hospitalisation with age, gender, and invalidity 
status 
The model is an extension of the socio-demographic model that tries to further distinguish 
potential high-expenditure individuals by relatively simple means. Individuals were also 
categorised based on their utilisation or non-utilisation of inpatient services (hospital inpatient 
stays of any length) in the risk year. Interactions between age/gender/invalidity and 
hospitalisation are accounted for.  
DCG/HCC model: Hierarchical condition categories (HCCs) with age, gender, and invalidity 
status 
In addition to the age/gender groupings described for the demographic model and the 
invalidity indicator, the model uses all of the reported inpatient diagnoses to categorise 
insurees into disease groups according to the DCG/HCC classification methodology. 
Preliminary analyses showed that accounting for interactions between age/gender and 
invalidity did not add substantially to the predictive performance of the diagnosis-based risk 
assessment model; hence the model adopts a simple additive relationship between age/gender, 
invalidity, and multiple diagnostic categories. 
Insurees' diagnostic classification in this study was implemented by DxCG
® Risk Adjustment 
Software, Release 6.1 (August 2002). This DCG/HCC grouping software version maps the 
ICD-9-CM diagnosis codes to 781 clinically homogenous groups (DxGroups), which are in 
turn grouped into 183 clinically related and resource homogenous condition categories (CCs). 
To exclude that minor diagnoses add to expenditure predictions, CCs are arrayed in 
hierarchies of related CCs, the HCCs. 
No amendments were made to insurees' diagnostic classification obtained from the grouping 
software save lumping HCC categories with less than eight cases in 1997 to form a residual 
  9risk category with enhanced statistical stability. Diagnostic groupings that contained no 
patients were discarded.  
In addition to a matrix of dichotomous diagnostic categories, the grouping software produces 
predicted expenditure scores, i.e. relative risk weights that have been normalised to have a 
weighted mean of 1.0 in the original benchmark sample on which they were developed
3. The 
study examined the usefulness of applying this “off-the-shelf” version of the DCG/HCC 
model to German sickness fund data: Besides a fully reparameterised model, an offered 
weights model was also calculated with the original, software-computed DCG/HCC relative 




A series of multivariable linear regressions was constructed to examine the ability of each of 
the risk assessment models summarised in table 1 in predicting year-1 and year-2 expenditure 
respectively. Specifically, year-1 (concurrent framework) or year-2 (prospective framework) 
annual expenditure was regressed on insurees' year-1 classifying variables that define the 
respective models
5. All independent variables apart the RRWs produced by the grouping 
software in the offered weights model were entered as class, rather than continuous variables. 
The analyses presented in this article focused on the models' predictive performance and did 
not dwell on the statistical significance of the included classifying variables. The specification 
of each model was forced; potential negative parameter estimates remained included and were 
not set to 0.  
Several researchers have proposed methods other than single-equation linear regression to 
estimate health services utilisation and expenditure because the distributional properties of 
these data are of statistical concern and may require transformation
6. Traditionally, linear 
regression has been the technique of choice for predicting medical risk. Research has 
                                                 
3 The offered risk weights were calibrated to total covered charges (fee-for-service and managed care) from the 
DCG/HCC model benchmarked to the 1997 to 1999 commercial population. 
4 Although the RRWs incorporate age and gender, the socio-demographic factors were entered separately in the 
regressions in order to recalibrate expenditure predictions, i.e., to have the predicted mean expenditure being 
equal to the actual mean expenditure in the German concurrent and prospective samples respectively. 
5 The single-equation WLS regressions that were constructed were in the form of Yit = Xitßi + Ui and Yit = Xit-1ßi 
+ Ui in retrospective and prospective modelling respectively, where Yit are annualised health care expenditures 
for the i
th person in year t (t = year 1 in the concurrent framework and t = year 2 in the prospective framework), 
Xit and Xit-1 are the demographic and diagnostic characteristics for the i
th person in year t (t = year 1 in the 
concurrent framework) or t-1 (t = year 1 in the prospective framework), ßi are the coefficients associated with 
each of the demographic and diagnostic characteristics and Ui is a disturbance term. 
6 See for example [2] 
  10demonstrated that ordinary least squares (OLS) or weighted least squares (WLS) regression is 
quite robust to asymmetric and highly skewed errors, though it ignores the mixed character of 
the underlying distribution of expenditure; with large sample sizes, even adequate efficiency 
can be achieved. Moreover, using OLS or WLS regression that retains the original scale of the 
response allows easy and meaningful calculation of an individual's risk profile by summing 
coefficients for each descriptor. Hence, for the sake of simplicity, robustness, and the ease of 
direct interpretation, this study stayed with employing the linear regression method and 
untransformed expenditure (i.e., euros)) rather than using alternative estimation approaches. 
Also, to predict per insuree per year (PIPY) expenditure and accommodate partial year 
insurance coverage in the prediction year – year 1 in the concurrent framework, year 2 in the 
prospective framework –, a weighting algorithm was used: Total per-person expenditure in 
the prediction year was annualised by dividing actual expenditure by the fraction of the 
prediction year that an individual had been insured. In subsequent calculations of means and 
regressions, each insuree's annualised expenditure was weighted by this same fraction. 
Annualising and weighting observations is needed to compute unbiased estimates of mean 
and total expenditure per year when each observation corresponds to a different sample size 
(in this case, the fraction of the year an individual is covered). 
In order to mitigate the potentiality of overfitting and avoid estimates of predictive accuracy 
that are upwardly biased, a 10-fold cross-validation approach was used: The data were 
randomly split into ten disjoint sets of nearly equal size which define ten different splits into 
calibration and validation sets, one-tenth of the data being the 1st,…, 10th validation set and 
the remainder of the data the 1st,…, 10th calibration set
7. Calculation required ten model 
calibrations; for each of the ten splits, measures of predictive accuracy were derived by 
computing expenditure estimates from the calibration set (within sample estimates) and 
applying them on the respective validation set as expenditure predictions (out of sample 
predictions). Predictive accuracy was then computed as the mean of the estimates of 
predictive accuracy for the ten validation data sets. A separate calibration-validation analysis 
was performed for each model in the concurrent and prospective applications [3]. 
                                                 
7, Practical experience with K-fold cross-validation suggests that a good strategy is to take K = min(n
1/2,10), on 
the grounds that taking K>10 may be computationally too intensive when the prediction rule is complicated, 
while taking groups of size at least n
1/2 should perturb the data sufficiently to give small variance of the 
estimate. 
  11Measures of predictive performance 
Several descriptive measures on the individual and group level were computed to gauge the 
models' relative predictive performance. Individual level predictive performance was 
measured using individual adjusted R-squared, the mean absolute prediction error, and 
Cumming's prediction measure; group level predictive performance was assessed employing 
predictive ratios of expenditure quintiles. 
Individual adjusted R-squared (R
2). R
2, the conventional regression-computed measure used 
to estimate model fit, describes the proportion of the individual variance in actual expenditure 
that is explained by a model. To use the measure for estimating predictive accuracy, R
2 values 
were produced over all observations in the validation data through applying the formula 
R
2  =  1 – ([∑i (ai – âi)
2] / [∑i (ai – ā)
2]) 
where ai is actual year-1 or year-2 expenditure for person i, âi predicted year-1 or year-2 
expenditure for person i, and ā the mean of actual year-1 or year-2 expenditure (i goes from 1 
to n, where n is the number of observations). In order to compare the predictive performance 
of models that varied substantially in complexity, the study computed adjusted R
2 values
8. 
Mean Absolute Prediction Error (MAPE). MAPE is defined as the mean of the absolute 
difference between actual and predicted expenditures across all individuals [4]. With this type 
of measure, predictions that are greater or less than actual expenditure cannot cancel each 
other out, as can happen with the mean prediction error. MAPE values over all observations in 
the validation data were derived as  
MAPE  =  (∑i |ai – âi|) / n 
Cumming's Prediction Measure (CPM). The concept of using the absolute value of the 
prediction errors rather than the square of the prediction errors as with R
2 when trying to 
summarise the predictive performance of various models on an absolute basis was developed 
in Cumming et al. [4]. It arose from concern about the sensitivity of R
2 to large prediction 
errors. CPM values over all observations in the validation data were calculated as 
CPM  =  1 – ([(∑i |ai – âi|) / n] / [(∑i |ai – ā|) / n])  =  1 – ([∑i |ai – âi|)] / [∑i |ai – ā|]) 
                                                 
8 Adjusted R
2 allows for the degrees of freedom of the sums of squares associated with R
2. Therefore, even 
though the residual sum of squares decreases or remains the same as new independent variables are added, the 
residual variance does not. Unlike R
2, adjusted R
2 can decline in value if the contribution to the explained 
variance by an additional variable is less than the impact on the degrees of freedom. Adjusted R
2 is calculated 
as R
2
adj. = 1 – ([1 – R
2] * [(n – i) / (n – p)]) where n is the number of observations, and p the number of 
independent variables including the intercept, with i = 1 if there is an intercept and i = 0 otherwise.  
  12Predictive ratio (PR) of expenditure quintiles. The PR is a group measure and can be 
calculated as the ratio or the aggregate predicted year-1 or year-2 expenditure for a given 
group of insurees g divided by the aggregate actual year-1 or year-2 expenditure for the same 
group g: 
PRg  =  ∑ig âig / ∑i aig  
The comparison gives the reciprocal of the common observed-to-expected actuarial ratio. A 
model predicts well for a group of insurees when it’s PR is close to 1.0; a PR greater than 1.0 
indicates overprediction, whereas a PR less than 1.0 indicates underprediction. Risk 
assessment models may generate predictions of differing accuracy for various ranges of the 
expenditure distribution; the study thus calculated PRs for groups of insurees defined by 
quintiles of (non-annualised) actual expenditure, assessing the strength of each model to 
predict expenditure for relatively high, medium, and low expenditure subjects. 
 
Additional investigations 
Truncation of expenditure 
To study the application of outlier risk-sharing in the context of risk adjustment, the models 
were also calculated using truncated expenditure. A first approach simulated the effect of an 
outlier threshold of € 20,000 in actual non-annualised expenditure on the predictive 
performance of the models; cases that exceeded the threshold were top-coded at the capped 
amount
9. The second approach fixed a € 10,000 deductible above the non-annualised 
expenditure predicted by the models, thus simulating the effect of a variable outlier threshold 
on the predictive performance of the models.  
Leavers versus Joiners versus Stayers 
Partial year insurees, i.e., “leavers” – those with any insurance cover in year 1 but not in year 
2 – and “joiners” – those with any insurance cover in year 2 but not in year 1 – present 
specific concerns with respect to risk assessment and adjustment. The main concern is that 
those individuals among the leavers and joiners who switch sickness funds (i.e., entrants and 
individuals opting out) may represent unique socio-demographic and health statuses relative 
to insurees with ongoing cover (stayers) and that they are, on average, much healthier and less 
expensive than the stayers, which lays the basis for potentially severe biased selection. Also, 
                                                 
9 The capped amount approximates the annual threshold of € 20.450 for the outlier risk-sharing arrangement of 
German SHI. German sickness funds would pay another 40% of the expenditure above the threshold amount 
and are compensated for the remaining 60% of the expenditure above the threshold out of the risk pool; this 
was not simulated in this study. 
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information about insurance cover for at least two years – diagnostic and/or demographic 
information of year-1 and year-2 length of cover and expenditure data) –, so analysis may 
have a selection bias.  
This study evaluated the concurrent findings for both study years, 1997 and 1998, separately 
for different sub-groups that composed the leavers, joiners, and stayers. Among the leavers, 
those who died in 1997 were distinguished from those who opted out of the fund (i.e., the 
switchers among the leavers); among the joiners, the newborn of 1998 were distinguished 
from entrants still alive at the end of 1998 (i.e., the switchers among the joiners); and among 
the stayers, distinction was drawn between the newborn of 1997, older insurees who were still 
alive at the end of 1998 (i.e., the non-switchers), and those who died in 1998. To assess the 
issue of turnover in the sickness fund's population, the concurrent mean expenditure predicted 
under each risk assessment model was compared with the actual mean expenditure separately 
for the switchers among the leavers, the switchers among the joiners, and the non-switchers. 
To explore the sensitivity of the prospective findings to the select group of insurees who had 
ongoing cover in both study years, model-specific concurrent predictive ratios for the 
newborn and the decedents among the leavers, joiners, and stayers were computed separately 
and tested for systematic over- or underprediction. 
Entitlement to LTC insurance benefits 
An additional analysis was performed to test the explanatory power of a binary indicator for 
persons who were entitled to benefits of long term care insurance (LTC). For that analysis the 
concurrent and prospective analyses were repeated using this indicator in lieu of and in 
interaction with the invalidity status variable. For the purposes of risk assessment, LTC status 
was defined as entitlement to LTC insurance benefits in at least one month during the risk 
year (i.e., all or part of 1997 in both the concurrent and the prospective framework). 
 
All additional investigations were performed using the overall concurrent and prospective 
samples without reserving portions for validation. With the large sample sizes used, the ten 
validation data sets yielded on average values for the performance measures that were similar 
to those found when estimating the models on the calibration data sets or on the overall 
samples. The DCG/HCC model using offered weights was no longer used, since it was found 
to be inferior in predictive performance to the reparameterised DCG/HCC model.  
SAS (version 8.2) was used for all analyses. 
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  153.  Results 
3.1  Descriptive statistics 
Descriptive statistics for the retrospective and prospective study samples are provided in 
Table 1. The sickness fund population was about 52% female in both years, with a mean age 
of approximately 46 years (SD 23.7); around 25% of insurees (33% of women, 16% of men) 
were age 66 and older. Most insurees (87.6%) had 12 months of cover in any study year. The 
mortality rate was 1.8% in both years. 
Annual health care expenditure in these samples, as elsewhere, was highly skewed. Year-1 
and year-2 expenditure average € 1,740 and € 1,762 respectively, with standard deviations 
being roughly 3 times larger than the mean. Only a small fraction of the population (about 
5.5%
10) did have no encounter with the health care system in 1997 or 1998 respectively. Also, 
in the prospective sample, year-2 expenditure of those who incurred no health care 
expenditure in year 1 was substantially less than (i.e., 32% of) average. The 1% of insurees 
whose expenditure was highest in any year used up about 20% of that year's total health care 
resources. For these high-users who had per-person expenditure of € 20,000 and more, 
truncated expenditure represented a little less than 60% of their total resource use. Roughly 
two-third of health care resources were consumed by 10% of insurees; reciprocally, the about 
50% of insurees with individual expenditure up to € 500 used less than 6% of total resources. 
In the prospective sample, the 1% of insurees with the highest year-1 expenditure used up 
about 9% of year-2 total health care resources. 
Between 16% and 17% of insurees were hospitalised in any study year, with inpatient 
expenditure comprising the largest portion (45-47%) of total reported expenditure. Not shown 
in table 1 is the clinical characterisation of the study population as implemented by the 
DCG/HCC grouping software. A total of 210,574 patient/diagnosis pairs for 127,905 (16.8%) 
insurees ever hospitalised in 1997
11 were submitted to the grouping software, corresponding 
to an average of 1.4 (SD 0.8, range 1-17) unique diagnosis codes per person hospitalised. 
About 38% of the hospitalised insurees were age 66 and older. Seventy-seven of the 210,574 
diagnoses submitted were incompatible with age or gender, 579 were identified as 
                                                 
10 Though substantially less than the percentage reported for the US (about 25%) or the Netherlands, this figure 
is in accordance with the findings by Breyer et al. (2003) for a sample of insurees covered by several smaller 
German sickness funds. 
11 Over 90% of insurees (i.e., 115,150) hospitalised in 1997 (year 1) were also covered by the fund in 1998 (year 
2). 
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of 32.5% of all diagnosis codes were 3-digit; V codes (factors influencing health status) 
comprised less than 0.05% of all codes, and there were no E codes (external causes of injury 
and poisoning). All insurees ever hospitalised were assigned to at least one HCC, if they hold 
a valid diagnosis code. Hospitalisations were primarily attributable to heart conditions 
(Aggregated Condition Category (ACC) 16 with 19.161 patients, i.e. a rate of 243/10.000), 
gastrointestinal conditions (ACC 07: 14.828 patients, rate 188/10.000), injury, poisoning and 
other complications (ACC 26: 14.550 patients, rate 185/10.000), malignant neoplasms (ACC 
02: 10.054, rate 128/10.000), and musculoskeletal and connective tissue conditions (ACC 08: 
9.900 patients, rate 126/10.000). The most frequently occurring HCCs were HCC 036 (“Other 
Gastrointestinal Disorders” with 7.482 cases), HCC 127 (“Other Ear, Nose, Throat, and 
Mouth Disorders”: 7.400 cases), HCC 043 (“Other Musculoskeletal and Connective Tissue 
Disorders”: 6.693 cases), HCC 162 (“Other Injuries”: 5.283 cases), and HCC 084 (“Coronary 
Atherosclerosis/Other Chronic Ischemic Heart Disease”: 4.992 cases). A number of HCC 
categories occurred rarely in the dataset. Eighteen HCC categories had no observation in 
1997; a further 6 of the 165 categories with observations had frequencies less than 8. The 
unadjusted and mean year-1 expenditure of the HCC categories exhibited a roughly 18-fold 
variation, ranging in round terms from € 2,000 for HCC 142 (“Miscarriage/Early 
Termination”) to € 36,000 for HCC 131 (“Renal failure”), which underlies the importance of 
risk adjustment. However, many HCC categories, especially those with low frequency, had 
quite wide 95% confidence intervals; two categories included negative values in their 
confidence intervals, for four categories with a frequency of 1 each no confidence interval 
was computable. 
 
3.2  Predictive performance 
Individual level predictive performance 
Table 2 summarises the predictive performance of the four risk assessment models and the 
DCG/HCC model with offered weights as measured by the R
2, MAPE, and CPM statistics. 
Both concurrent and prospective findings are reported; all of the presented statistics are means 
of the estimates of predictive performance computed for the ten validation data sets in 10-fold 
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12. Higher R
2 and CPM values and lower MAPE values indicate better 
predictive performance. 
Concurrent approach. As expected, the demographic age/gender and socio-demographic 
age/gender/invalidity models were the least predictive models, regardless of the measure used. 
There were substantial increases in predictive performance, however, when insurees who 
were hospitalised were distinguished from those who were not, and even more when the 
diagnostic information for those hospitalised was taken into account. Based on adjusted R
2, 
the demographic model explained little more than 3% of the variance in total actual 
expenditure
13. Incorporating invalidity status brought a relatively modest gain with an 
adjusted R
2 of 5.1 %. The simple addition of a binary variable for hospitalisation achieved an 
adjusted R
2 value of about 25%, nearly an 8-fold improvement over the demographic model. 
Finally, with an adjusted R
2 value of more than 37%, the predictive performance of the 
reparameterised DCG/HCC model represented a 12-fold improvement over that of the 
demographic model. 
MAPE and CPM provided the same rankings of the models' predictive performance as 
adjusted R
2, though the magnitudes of the models' relative improvements differed across the 
measures. By decreasing MAPE from about € 1,850 to around € 1,200 and € 1,000 
respectively, the hospitalisation and reparameterised DCG/HCC models outperformed the 
demographic model by 33% and 42%. With CPM values of roughly 38% and 46%, the two 
models performed roughly 5.5 times (hospitalisation model) and 7 times (reparameterised 
DCG/HCC model) better than the demographic model (CPM of 7%) did.  
Table 2 also shows the significant increase in performance due to reparameterising the 
DCG/HCC model to the German sickness fund population rather than using the HCCs with 
the offered relative risk weights. This might be expected since the standard set of relative risk 
weights was calibrated for a US commercial population. Reparameterisation of the DCG/HCC 
model increased its general performance by approximately 20% as measured by adjusted R
2, 
by 9% based on MAPE, and by 13% when using CPM as the measure. 
                                                 
12 When averaged over the ten validation sets, the estimates of predictive performance computed in 10-fold 
cross-validation differed only insignificantly from the averaged estimates obtained in the calibration data sets 
or when fitting the models on the entire concurrent and prospective samples, indicating a good overall fit 
between predicted and actual expenditure for all models. Averaged year-1 and year-2 predicted means were 
equal to actual year-1 and year-2 mean expenditure.  
13 The reported concurrent and prospective R
2 values for the demographic model, though small, are higher than 
those found in most of the international studies. This might be due to a comparatively lower expenditure 
variance in German data: while US and Dutch studies display coefficients of variation of more than 4.0, the 
coefficients of variation determined in the present study were below 3.0 (and thus in accordance with the one 
reported by [1]). 
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predicted by age/gender and HCCs alone. Although incorporating invalidity status in the 
DCG/HCC model had only a relatively small impact on individual performance measures – 
for instance an increase of adjusted R
2 from 36.9% for a reparameterised age/gender-HCCs 
model (results not shown) to 37.3% for the reparameterised age/gender-invalidity-HCCs 
model –, the analyses showed that, if this factor was not taken into account in the estimations, 
the model would not predict the average expenditure of this important and easily observed 
higher-expenditure subgroup, leading to an underpayment of these insurees if such an 
adjustment was not included. 
Prospective approach. The prospective findings in table 1 show the same rankings of the 
models' predictive performance as the concurrent results. However, when changing from the 
concurrent to the prospective application, the health-status based risk assessment models 
predicted much less of the variation in year-2 expenditure than the concurrent models did for 
year-1, whereas the difference is almost negligible for the demographic and 
demographic/invalidity model; therefore the gain in predictive performance for these models 
over the demographic model was thus much smaller. The prospective R
2 values ranged from 
3.1% for the age and gender model to 7.1% for the hospitalisation and 11.7% for the 
reparameterised DCG/HCC models. When using MAPE as the measure, the decrease from € 
1,902 to € 1,786 and € 1,738 corresponded to a gain in predictive performance for the 
hospitalisation and the reparameterised DCG/HCC models over the demographic model of 
roughly 6% and 8.5% respectively. Based on CPM, the difference in the relative improvement 
between the hospitalisation and the reparameterised DCG/HCC models was even less 
pronounced, the hospitalisation model (CPM of 13.2%) performing 2.1 times and the 
DCG/HCC model (CPM of 14.4%) 2.3 times better than the demographic model (CPM of 
6.3%). 
Group level predictive performance 
The relative rankings of the models remained unchanged when their concurrent and 
prospective predictive performances for groups of insurees with relatively high, medium, and 
low expenditure were evaluated. Table 3 displays the PR results for insurees grouped by 
quintiles of (non-annualised) actual expenditure. Quintile 1 (Q-1) represents the 20% of the 
population that had the lowest expenditure and quintile 5 (Q-5) represents the 20% of the 
population that had the highest expenditure. Specifically, Q-1 had actual year-1 and year-2 
expenditure of € 53 and € 55 per insuree per year (PIPY) respectively and Q-5 of € 6,584 and 
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of € 1,740 and € 1,762 respectively). 
Not surprisingly, the age and gender model is grossly overpaying for the low expenditure 
quintile Q1, giving a PR of 24 (concurrent) and 23 (prospecitve) for this group of insured; on 
the other hand it is grossly underpaying for the high expenditure quintile Q5, giving a PR of 
0.3 (both, concurrent and prospecitve). In comparison to that, all other models perform better. 
In line with the individual level results, the reparameterised DCG/HCC model did perform 
best in both the concurrent and prospective application and over all expenditure quintiles; 
however also with this model there is still over-payment for the low-expenditure insured (with 
a PR of 21 concurrent and prospective) and under-payment for the high-expenditure insured 
(with a PR of 0.8 in concurrent and 0,5 in the prospecive application). The PR values obtained 
with the simple binary hospitalisation variable, almost reached the results for the 
reparameterised DCG/HCC model. 
In all modells, the prediction errors were larger for insurees with expenditure levels farther 
from the mean. With a prospective model application, the differences between the models' 
predictive performances are small for the middle 60% of the expenditure distribution; the 
greatest difference in these middle three expenditure quintiles amounts to a 22% more 
accurate (over)prediction for the reparameterised DCG/HCC model (PR of 4.8) relative to the 
demographic model (PR of 5.9). In concurrent application, the differences between the 
models' predictive performances in the middle 60% of the expenditure distribution are greater; 
the smallest difference was observed in the 4th quintile with the DCG/HCC model (PR of 1.1) 
giving a 63% better (over)prediction of group expenditure than the demographic model (PR of 
1.8). 
For both the least and most expensive insurees, all four models did a more or less poor job in 
predicting expenditure concurrently or prospectively; similar to the findings for the middle 
three expenditure quintiles, the differences between the models' predictive performances in 
the two outer quintiles were much more pronounced in the concurrent than in the prospective 
application. The PRs in these two quintiles reflect the range and degree of “skewness” of 
expenditure predictions. PRs for Q-1 were quite high mainly because actual expenditure 
levels in this quintile were as low as or closely above zero whereas none of the risk 
assessment models could predict an expenditure close to zero. In their concurrent and 
prospective applications, the minimum predicted annual amounts ranged from € 566 and € 
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14 for the reparameterised DCG/HCC 
model respectively. At the other end of the expenditure distribution, PRs for Q-5 were below 
1.0 as no insuree could be expected to have expenditure levels 300 times above average. The 
maximum annual prediction values for the reparameterised DCG/HCC model totalled to € 
72,623 when applied concurrently and € 58,458 when applied prospectively, i.e., not even a 
50-fold of the mean. The reparameterised DCG/HCC model thus achieved an extended upper 
tail by predicting less in the lower and middle parts of the expenditure distribution. In 
contrast, the demographic model's maximum predicted annual expenditure – € 3,732 for the 
concurrent and € 3,712 for the prospective application – amounted to a little more than twice 
the mean.  
 
3.3  Additional investigations 
Truncation of expenditure 
To simulate the effects of outlier risk-sharing on the models' predictive performance, two 
different approaches of truncating actual expenditure were applied. The results in table 4 are 
based on the truncation of expenditure at a pre-specified threshold, i.e., cases exceeding € 
20,000 in actual, non-annualised expenditure were top-coded at that amount. The results in 
table 5 pertain on the other hand to the application of a variable truncation threshold in that 
actual expenditure was truncated at a € 10,000 deductible above the non-annualised predicted 
expenditure.  
None of the truncation approaches appeared to cause any significant changes in the overall 
relative performance of risk assessment models compared with each other. In general, for both 
the concurrent and prospective applications, similar model-specific improvements in each of 
the measures were observed: expenditure truncation induced an increase in the adjusted R
2 
and CPM values, a decrease in the MAPE values, and tended to bring the PRs closer to 1.0. 
The improvements were not dramatic, though, with MAPE, CPM, and the PRs being less 
sensitive to expenditure truncation than adjusted R
2. The CPM measure for instance showed a 
model-specific increase by 5-10% in the pre-specified truncation threshold approach and by 
10-20% in the variable truncation threshold approach as compared to the findings of table 2 
based on untruncated expenditure; in terms of adjusted R
2, the model-specific increases were 
                                                 
14 The prospective reparameterised DCG/HCC model also generated negative predicted expenditure for three 
individuals aged 18 and younger who had all three hospitalised in year 1 (and in year 2) with a diagnosis 
included in HCC 5 (“Opportunistic infections”). 
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2 squares the prediction errors, it can 
be overly affected by a relatively small number of high-expenditure case and increases with 
lower thresholds for truncation; this is less an issue with MAPE and CPM. The more health 
status information the models included, the less the measures of predictive performance 
improved when expenditure was truncated. The differing mean expenditure levels in the 
variable truncation threshold approach suggested that the better a risk assessement model 
predicts the upper tail of the expenditure distribution and reproduces the skewness of health 
care expenditure, the less important in magnitude the reallocations of the outlier risk-sharing 
approach will be. 
Leavers versus Joiners versus Stayers 
Approximately 7% of the individuals insured with the sickness fund in 1997 were not in the 
fund in 1998 (leavers). Of those covered by the fund in 1998, 3% were not in the fund in 1997 
(joiners). The mean expenditure for the leavers was roughly 2.5 times as high as that for 
insurees who were in the fund in both study years (stayers), whereas the mean expenditure for 
the joiners was about 15% lower as compared to the mean expenditure of stayers. 
The three groups comprise varying percentages of newborn, decedents, and/or individuals 
entering or opting out of the fund. The leavers' relatively high mean expenditure was 
primarily due to the high expenditure of insurees in their last year of life. With € 14,800 
PIPY, expenditure for leavers who died in 1997 was similar to that for stayers who died in 
1998. Also, the switchers among the leavers and joiners – i.e., those opting out (leavers who 
were still alive at the end of 1997) and those entering (joiners who were still alive at the end 
of 1998) – were, on average, younger, healthier, and only half as expensive as the non-
switchers (stayers who survived throughout 1997 and 1998) – the differences in expenditure 
ranged from € 657 PIPY for the leaving switchers to € 760 for the joining switchers. 
Figure 1 depicts the differences between predicted mean expenditure and actual mean 
expenditure under each risk assessment model for the three sub-groups of the non-switchers, 
the switchers among the leavers (switchers: out), and the switchers among the joiners 
(switchers: in). A positive difference involved a predictable gain for the sickness fund; a 
negative difference equalled a predictable loss. In a concurrent risk adjustment scheme based 
on the demographic model, switchers represented "good risks" insofar as their mean predicted 
expenditure was higher than their actual mean expenditure and even higher than the mean 
predicted expenditure for the non-switchers. Using a socio-demographic risk assessment 
model reduced the demographic model's mean predictable gain of 1997-€ 198 for the leaving 
switchers and 1998-€ 262 for the joining switchers by roughly 60%. The hospitalisation 
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these individuals, on average, to "bad risks"; the mean predictable loss ranged from 1997-€ 74 
to 1998-€ 8 respectively (compared to the demographic model's mean predictions, the loss 
amounted to roughly € 270 for both for the leaving and the joining switchers). The DCG/HCC 
model further increased the predictable loss to 1997-€ 87 PIPY for the leaving switchers and 
to 1998-€ 35 PIPY for the joining switchers. As for the non-switchers, the more health 
information the risk assessment model incorporated, the better the mean predictions matched 
the actual mean expenditure for this sub-group.  
The results summarised in Table 6 show that the model-specific predictive ratios for the two 
sets of comparison groups – the decedents, i.e., leavers dying in 1997 and stayers dying in 
1998, and the newborn, i.e., joiners born in 1998 and stayers born in 1997 – were similar. For 
the newborn, no systematic differences in the ratios across models were observed, the ratios 
being all close to 1.0. In contrast, the predictive ratios for decedents varied systematically 
across models: the DCG/HCC model performed roughly 3.4 times better than the 
demographic model, significantly reducing the underpredictions for this group. The decrease 
of the underpredictions for decedents ran concurrent to the reduction of the model-specific 
overpredictions for the sub-group of the non-switchers. 
Entitlement to LTC insurance benefits 
The findings in tables 2 and 3 suggest that the invalidity indicator may be considered as a 
weak proxy measure for the unique expenditure implications of characteristics not related to 
hospital admissions. The results in table 7 indicate that the same holds for the LTC indicator. 
Using it in lieu of the invalidity indicator showed model-specific concurrent and prospective 
predictive performances similar to that of the invalidity indicator's one. Using the LTC 
indicator in combination with the invalidity indicator further improved, albeit marginally, the 
individual and group level predictive performances for all models with the exception of the 
hospital model. When applied concurrently, the latter model performed less well in predicting 
individual expenditure when incorporating both, the invalidity indicator and the LTC 
indicator, than when using either of them; the concurrent group level predictive performance 
in contrast improved considerably with the inclusion of both indicators.  
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  244.  Discussion 
4.1  Discussion of findings 
Effective risk adjustment is a crucial aspect of competitive health insurance system with non-
risk related premiums. The effectiveness of any risk adjustment approach will depend on 
accurate risk assessment. Germany’s Risk Equalisation Reform Act of 2001 makes provisions 
for implementing a risk assessment formula that accounts for insurees’ health status, as this 
may help reorient the current incentive structure in the sickness fund market and reduce the 
negative consequences of enrolling high-risk users by compensating sickness funds for health 
care needs which persits with the existing socio-demographic risk adjustment formula. 
The 2001 legislation explicitly states that pertinent international risk assessment methods be 
adopted. The limited availability, completeness and validity of administrative health 
information  to German sickness funds, however, potentially threaten the applicability and 
validity of these methods. Moreover, their external validity may be questioned as the 
underlying disease classifications are based on data of populations with specific 
demographics, coverage, utilisation and provider practice patterns, coding methodologies, 
provider reimbursement policies, and prices. 
The issue of applying and generalising such methods to the German situation thus necessitates 
thorough investigation. This is the first published study that explores the use of a US-
American diagnosis-based risk assessment approach on data of a German sickness fund 
population and compares its performance to that of models with socio-demographic variables 
alone or in combination with an indicator for use of inpatient services as indirect markers for 
health status.  
The investigated models are based on the most prevalent and accessible source of  health 
information in Germany, claims for inpatient utilisation. Applying the DCG/HCC 
classification system to the available data proves to be technically feasible. The analyses of 
the HCC-specific expenditure levels suggest that the HCC system applied to German data 
shows substantial face validity in quantifying morbidity on the basis of expected levels of 
health care expenditure for sickness funds. Despite the sole use of 3- and 4-digit ICD-9(-CM) 
codes, the HCC system performed reasonably well. However, the system could perform 
differently (and presumably better) if coding was enhanced – some DxGroups and 
consequently HCCs are, for instance, not created when applied to ICD-9 data because of 
missing fifth digits (e.g., (H)CC 20, type I diabetes mellitus, requires the specificity of the 
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inpatient-only data of this study’s sample show that DxCG’s clustering of DxGroups in 
condition categories (CCs) on the basis of medically related problems with similar expected 
expenditure is not always indicated with the mean expense for DxGroups. Also, the 
descriptive data show in part large variances in estimated mean expenditure for HCCs, 
especially in groupings with low frequencies. Groupings with low frequencies may represent 
unstable values for estimation purposes. This matter is vitally important for implementation of 
risk adjustment, as capitation payments for cases with low prevalence may be incorrectly 
estimated with consequential over- or under-funding. Even with a larger sample then that 
available for this study, it might be necessary to pool HCCs (or even DxGroups) to diagnostic 
subgroups of a specified minimum sample size to obtain parameter estimates that are 
statistically robust. 
The results of this study indicate that, at the individual level, each of the utilisation-based risk 
assessment models is able to explain a much greater proportion of the variance in total health 
expenditures than the socio-demographic model currently in use. The standard reference 
model based on age and gender explains less than 4% of the variance in expenditures whereas 
the reparameterised HCC model could explain around 37% of the variance in concurrent 
resource use and 11-12% in prospective resource use. The reduction in explanatory power of 
the prospective models compared with the concurrent ones is expected given that only a 
portion of future costs is predictable on the basis of past utilisation (or morbidity) patterns. 
Van de Ven & Ellis argue that around 20% is “the lower bound on the upper bound” of the 
proportion of variance in expenditures that is potentially predictable in prospective risk 
modelling.[1] If this is the case, the DCG/HCC model we tested explained about one half of 
what could be maximally predicted. The concurrent models tend to improve the non-
demographic model’s explanatory power. As they approach cost-based reimbursement and 
return, in essence, risk to the consumer, they muddle the incentives to sickness funds for 
efficiency. For the privately-insured benchmark US-population on which the reference (“off-
the-shelf”) risk weights were computed, R
2s obtained by the DCG/HCC explanation models 
on the basis of inpatient diagnoses are 44.6% and 7.9% when used to predict same year and 
subsequent year resource use respectively. The R
2s obtained in the risk-adjusted models of 
this study, which could only predicate on the single primary diagnosis per hospital episode, 
are somewhat lower in the concurrent case and higher in the prospective case. The 
comparison is rendered difficult by the fact that DxCG’s commercial benchmark population is 
for the most part an under-65 population with a different distribution of illness burden. The 
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from populations other than the original development populations. Duckett & Agius tested the 
ability of the DCG/HCC model (release 5.2, May 2001) to predict resource use of participants 
with any use of services in the first-round Co-ordinated Care Trial (CCTs). Based on inpatient 
diagnostic information, age, gender, socio-economic status and HCCs explained around 46% 
of variation in concurrent year log-transformed expenditures [2]. With prospective 
(subsequent) year modelling, explanatory power was weaker, explaining about 18% of 
variation in total log-transformed expenditures. Based on both inpatient and ambulatory 
diagnostic information, about 45% and 23% of variation in concurrent and subsequent year 
log-transformed expenditures respectively were explained. Especially the use of the logarithm 
of expenditures complicates the comparison of the Australian results with ours. According to 
Van de Ven & Ellis, using a log transformation inflates the conventional R
2 by about 100%. 
Also, sample sizes were relatively small and predictions were only made for a population with 
any services utilisation. Rosen et al. examined the feasibility of adapting the DCG/HCC 
model (release 4.2) to the population covered by the US Department of Veterans Affairs (VA) 
who had some health service use during a 12-month sample period [3]. The dependent 
variables in this study were utilisation-based rather than expenditures. Predictive power for 
concurrent “off-the-shelf” prediction of ambulatory provider encounters was 7.7%; a 
combined inpatient and ambulatory visit measure was higher, at 19.4% of variance explained. 
Reparameterisation of the DCG/HCC model enhanced performance considerably, to 24.4% 
for predicting ambulatory provider encounters and 31.4% for service days’ prediction. 
Overall, given the social, epidemiological and economic differences in the populations studied 
as well as the distinctions in the organisation and financing of their respective health care 
systems, the international comparability and generalisability of predictive power across 
studies is limited.  
4.2  Limitations 
In this study, only the principal inpatient diagnosis for each hospital stay was available to 
estimate total sickness fund’s expenditure for its insured. Although inpatient diagnoses-based 
risk assessment represents a substantial improvement over socio-demographic assessment 
alone, many insurees – also particularly ill and high-expenditure subsets of insurees – are not 
hospitalised in a given year, so that their condition histories remain unknown and are not used 
for upwards adjustment in the inpatient diagnosis-based model. We found that only 16% 
percent of our sample had had at least one inpatient stay in the base year, but that 95% in total 
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information – for instance diagnoses from outpatient provider encounters or anatomical 
therapeutic chemical (ATC) codes for prescribed drugs –, the number of persons able to be 
classified to discriminating risk adjustment categories is substantially reduced. An additional 
outpatient grouper should undoubtedly improve measures of enrolee health risk. 
The invalidity status indicator may be considered as a weak proxy measure for the unique cost 
implications of characteristics not related to hospital admissions. It indisputably increases the 
accuracy of the capitation estimates for a higher-than-average risk subgroup of the population; 
we reason, however, that its predictive power is impaired in that entitlement to disability 
benefits is restricted to the under-65 and there are no references whatsoever sickness funds’ 
administrative databases to identify the originally disabled aged 66 and older. In this regard, a 
tantamount, if not more effective alternative to reflect the costs of characteristics not related to 
hospital episodes is the inclusion of a LTC status indicator in lieu of or in addition to the 
invalidity status variable (data not shown), as entitlement to LTC benefits is independent of 
age. 
Risk sharing arrangements – such as proportional, outlier, high-risk and condition-specific 
risk sharing – are considered necessary when risk adjustment is imperfect. The use of such 
arrangements presents an efficiency-risk selection trade-off. The need for risk sharing 
protection remains after the implementation of health-based risk-adjustment. However, the 
structure of this protection may need to be revised. With outlier risk sharing for instance there 
may be some diagnoses for which the risk-adjusted payment rate may exceed the threshold 
amount (i.e. the sickness fund’s deductible level). Given the possibility of payment rates for 
particular diagnoses that are above the sickness funds’ deductible levels, appropriate 
modifications to risk sharing arrangements should be made. 
Beyond the inclusion of only inpatient diagnostic information, this study has some other 
limitations that should be considered when interpreting its results. First, there may be limits to 
the generalisability of our findings. Though our study sample comprised a diverse group of 
non-elderly and elderly SHI individuals, we did not have data from other sickness fund 
populations. Second, we used a version of the DxCG with ICD-9-CM codes and had to rely 
on crossovers between the German ICD-9/10 version and the US coding version. Also, the 
lack of coded secondary diagnoses and the use of less specific 3-digit ICD-9 codes may bias 
in favour of lower-acuity HCC assignments. Third, the investigation of the complex practical 
issues that partial-year enrolees represent was beyond the scope of this study. Partial-year 
  28enrolment can occur when enrolees join or disenroll from a sickness fund and also because of 
births and deaths. Partial-year enrolment can also result from changes in eligibility that occur 
throughout the year. For example enrolees can gain, lose, and regain eligibility for exemption 
from co-payments during the course of a year. Limiting in the prospective analyses the sample 
frame to enrolees eligible during all or part of 1997 and enrolled during part or all of 1998 
means that babies born in the prediction year were not included in the analysis because they 
do not have any diagnostic experience in the base year. Infants with severe birth defects and 
neonates who were born prematurely can be substantially more expensive to care for than 
infants without such problems. Correction by incorporating newborns’ expenditures with 
those of their mothers was not possible, because the anonymous individual identifiers did not 
allow of linking mothers’ and children’s data. Excluding partial-year enrolees from the 
prospective sample frame represents a limitation of this study, because a fair and equitable 
capitation method must adjust for these enrolees.  
Large prediction errors can end up dominating the calculation of R
2. As a result, significant 
improvements in the predictive accuracy for people with small or medium size expenditure 
might have little or no impact on the R
2 measure. The corollary to this statement would be 
that R
2 is unduly insensitive to improvement in predictions for small or medium size 
expenditure. In calibrating the models in this study, a linear regression model was used which 
minimizes the means square prediction error and why some researcher argue that R
2 is the 
most appropriate measure. Accordingly, the R
2 measure corresponds to the way the risk 
weights are calibrated. The authors of this article agree with Cumming et al., that one should 
first define what is believed to be the most appropriate measure (or measures) of predictive 
accuracy and let that drive the way the model calibrated rather than vice versa. If CPM is 
adopted as a new standard in measuring predictive accuracy, this might impact the way 
models are calibrated. In particular, calibration methods that attempt to minimise the mean 
absolute prediction error, rather than mean square prediction error, might lead to further 
improvements in model performance. It might also be surmised that methods that try to 
minimize the mean absolute prediction error might lead to more stable and reasonable risk 
weights since such methods are not impacted as much by a few large claims. The sensitivity 
of R
2 to the level of expenditure truncation also leads to a variety of opinions regarding what 
is the "right" or "optimal" level of expenditure truncation for analysing predictive 
performance. CPM is similar in magnitude to R
2. However, CPM tends to me more stable as 
the level of expenditure truncation is changed. CPM is sometimes higher and sometime lower 
than R
2. Use alternative methods of model calibration. Specifically, the impact of using 
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methods that try to minimise the mean absolute prediction error as opposed to methods that 
minimise the mean square prediction error.  
In conclusion, risk adjustment based on socio-demographic factors is inadequate in predicting 
resource use, so that health status risk assessment and adjustment should continue to play an 
important role in Germany’s health care reform strategies. The primary shortcoming of an 
inpatient diagnosis-based model as the one explored in this study is its failure to account for 
conditions treated in ambulatory settings that predict expense. This shortcoming results in 
systematic over-payments for healthy enrolees and under-payments for enrolees with serious 
conditions who were not hospitalised in the same or previous year. A multiple-site model 
requires much more data than does an inpatient diagnosis-based model, raising concerns about 
coding practice, data collection and processing, incentive structures, implementation, and cost 
that will challenge German sickness funds, providers, scientists, and politicians. Limitations 
associated with data availability and validity suggest the need for further research to develop 
and test utilisation-based risk adjusters for Germany. One approach might be to construct a 
combined model that incorporates risk-adjusters form different international methods. 
However, further research is needed to confirm the appropriateness of this method and to 
identify which risk-adjusters demonstrate consistency across various subgroups of the 
German SHI population. Overall, the practical application of a health-based risk capitation 
payment model will involve “a series of trade-offs between risk adjustment theory, data 
availability, and the willingness of participants [and stakeholders] to play the game”.  
Apart from improving risk adjustment it should be emphasized finally, that good risk 
adjustment is a necessary but not a sufficient condition for a competitive system of health 
insurance with non-risk related premiums to lead to improvements in efficiency in health care 
production. What is needed urgently as well is a regulatory framework which allows sickness 
funds to behave as prudent buyers of health care services – such a framework is far from 
being implemented in the corporatist structures of the German health insurance system. 
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Tables 
 
Table 1:  Demographics, expenditure and inpatient experience of the sickness fund population 
  Concurrent application  Prospective application 
N 788,130  733,378 
Year(s) 1997  1997/1998 
% female  51.4  51.9 
Age    
 Mean  45.4  45.7 
  % age under 18  17.2  17.1 
  % age 18-45  32.8  31.9 
  % age 46-65  25.5  26.3 
  % age over 65  24.5  24.7 
Mean months of cover     
 Year  1  11.4  11.7 
 Year  2  --  11.6 
Year-1 expenditure     
  Mean  € 1,740  € 1,643 
  Standard deviation  € 5,106  € 4,222 
  Coefficient of variation (x 100)  294  257 
  Median  € 518  € 523 
Year-2 expenditure     
 Mean  --  €  1,762 
  Standard deviation  --  € 5,256 
  Coefficient of variation (x 100)  --  298 
 Median  --  €  513 
% with non-zero expenditure     
 Year  1  5.8  4.9 
 Year  2  --  4.7 
% ever hospitalised     
 Year  1  16.2  15.7 
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Table 2:  Summary of individual level predictive performance – 10-fold cross-validation 
mean 
  Concurrent application  Prospective application 
N  78,813 (x 10)  73,337 (x 10) 
Mean expenditure  €  1,740  €  1,762 
Risk Adjustment Model  MAPE R
2
adj. CPM MAPE  R
2
adj. CPM 
  [€] [%]  [%]  [€] [%]  [%] 
Age*Gender  1,842    3.2    6.7  1,902    3.1    6.3 
Age*Gender*Invalidity  1,795    5.1    9.0  1,862    4.5    8.3 
Age*Gender*Invalidity*HOSP  1,227 24.6  37.8  1,786     7.6  12.0 
Offered weights DCG/HCC: 
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Table 3:  Summary of group level predictive performance for actual (non-annualised) 
expenditure quintiles – 10-fold cross-validation mean 
   Concurrent application    Prospective application 
      
Mean    Mean    Risk Adjustment Model 
MP 
MAPE PR   MP 
MAPE PR 
  [€]  [€]      [€]  [€]   
Q-1  Actual       53             55    
  Age*Gender  1,262 1,209 24.0    1,283 1,227 23.2 
  Age*Gender*Invalidity  1,101 1,048 20.9    1,147 1,092 20.7 
  Age*Gender*Invalidity*HOSP     490     439    9.3    1,008     953  18.2 
  Age*Gender Invalidity RRWs     563     511  10.7    1,021     966  18.4 
  Age*Gender Invalidity HCCs     463     412    8.8       981     926  17.7 
Q-2  Actual     220           229    
  Age*Gender  1,273  1,054    5.8    1,362  1,134    5.9 
  Age*Gender*Invalidity  1,158     939    5.3    1,265  1,037    5.5 
  Age*Gender*Invalidity*HOSP     518     306    2.4    1,154     926    5.0 
  Age*Gender Invalidity RRWs     586     373    2.7    1,144     917    5.0 
  Age*Gender Invalidity HCCs     481     284    2.2    1,109     881    4.8 
Q-3  Actual     508           512    
  Age*Gender  1,714  1,213    3.4    1,755  1,248    3.4 
  Age*Gender*Invalidity  1,650  1,151    3.2    1,711  1,205    3.3 
  Age*Gender*Invalidity*HOSP     779     399    1.5    1,594  1,095    3.1 
  Age*Gender Invalidity RRWs     899     508    1.8    1,572  1,071    3.1 
  Age*Gender Invalidity HCCs     749     417    1.5    1,536  1,041    3.0 
Q-4  Actual 1,185        1,151    
  Age*Gender  2,128  1,120    1.8    2,092  1,115    1.8 
  Age*Gender*Invalidity  2,203  1,262    1.9    2,160  1,230    1.9 
  Age*Gender*Invalidity*HOSP  1,416     780    1.2    2,135  1,246    1.9 
  Age*Gender Invalidity RRWs  1,483     775    1.3    2,081  1,195    1.8 
  Age*Gender Invalidity HCCs  1,300     689    1.1    2,068  1,201    1.8 
Q-5  Actual 6,584        6,815    
  Age*Gender  2,263  4,567    0.3    2,289  4,780    0.3 
  Age*Gender*Invalidity  2,511  4,513    0.4    2,490  4,732    0.4 
  Age*Gender*Invalidity*HOSP  5,384  4,147    0.8    2,878  4,690    0.4 
  Age*Gender Invalidity RRWs  5,061  3,634    0.8    2,953  4,652    0.4 





Table 4:  Summary of predictive performance with expenditure truncation at € 20,000 of 
actual (non-annualised) expenditure – individual results and results for actual (non-
truncated) expenditure quintiles 
Risk Adjustment Model  MAPE R
2
adj. CPM     PR    
  [€]  [%]  [%]  Q-1 Q-2 Q-3 Q-4 Q-5 
  Concurrent application 
N  788,130 
Mean expenditure  €  1,613 
Age*Gender  1,646    6.0    7.4  22.0 5.3  3.1  1.7  0.4 
Age*Gender*Invalidity  1,602    8.5    9.8  19.7 4.9  3.0  1.7  0.4 
Age*Gender*Invalidity*HOSP  1,055  40.3  40.6    9.2 2.3  1.5  1.1  0.8 
Reparameterised DCG/HCC: 
Age*Gender Invalidity HCCs 
 















  Prospective application 
N  733,378  
Mean expenditure  €  1,623 
Age*Gender  1,685    6.1    7.0  21.1 5.5  3.2  1.7  0.3 
Age*Gender*Invalidity  1,648    8.0    9.0  19.2 5.1  3.1  1.7  0.4 
Age*Gender*Invalidity*HOSP  1,578  12.5  12.9 17.1 4.7 2.9 1.7 0.4 
Reparameterised DCG/HCC: 





















  35Table 5:  Summary of predictive performance with expenditure truncation at € 10.000 above 
predicted (non-annualised) expenditure – individual results and results for actual 
(non-truncated) expenditure quintiles 
Risk Adjustment Model  MPC  MAPE R
2
adj. CPM    PR    
  [€]  [€]  [%]  [%]  Q-1 Q-2 Q-3 Q-4 Q-5 
  Concurrent application 
N  788,130 
Age*Gender 1,499  1,473  8,1  8,1  20,4  5,0  2,9  1,6  0,4 
Age*Gender*Invalidity 1,509  1,445  10.9  10.6  18.5  4.6  2.8  1.6  0.4 
Age*Gender*Invalidity*HOSP  1,587  1,021  46.4  41.2    9.2  2.3  1.5  1.1  0.8 
Reparameterised DCG/HCC: 



















  Prospective application 
N  733,378 
Age*Gender  1,501  1,501    8.1    7.5  19.5  5.1  2.9  1.6  0.4 
Age*Gender*Invalidity  1,509  1,476  10.3    9.7  17.9  4.8  2.9  1.6  0.4 
Age*Gender*Invalidity*HOSP 1,524 1,432  15.7  13.6  16.2  4.5  2.7  1.6  0.4 
Reparameterised DCG/HCC: 
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Table 6:  Retrospective actual and predicted mean expenditure, mean absolute prediction 
error, and ratio of predicted to actual expenditure for newborn and deceased leavers, 
stayers, and joiners by risk assessment model and reference model 
Mean Mean  MAPE PR  Risk Adjustment Model 
MP 
MAPE PR 
MP    
 [€]  [€]      [€]  [€]   
  Year: 1997    Year: 1998 
  Leavers deceased in 1997 (n = 13,863) 
Actual 14,734             
Age*Gender    2,969  12,514  0.20         
Age*Gender*Invalidity    3,178  12,382  0.22         
Age*Gender*Invalidity*HOSP    6,757  10,002  0.46         
Age*Gender Invalidity HCCs    9,918    8,845  0.67         
  Stayers deceased in 1998 (n = 13,753) 
Actual 6,180        14,846     
Age*Gender  2,963  5,206  0.48      3,018  12,664  0.20 
Age*Gender*Invalidity  3,137  5,155  0.51      3,218  12,527  0.22 
Age*Gender*Invalidity*HOSP  4,369  3,743  0.71      6,776  10,103  0.46 
Age*Gender Invalidity HCCs  5,464  3,264  0.88    10,158    8,844  0.68 
   
   
  Joiners born in 1998 (n = 3,784) 
Actual         4,041     
Age*Gender
#        4,134  5,216  1.02 
Age*Gender*HOSP
#        4,123  3,636  1.02 
Age*Gender HCCs
#        4,135  3,084  1.02 
  Stayers born in 1997 (n = 3,854) 
Actual 3,658        1,692     
Age*Gender
# 3,816 4,669 1.04    1,077 1,704 0.64 
Age*Gender*HOSP
# 3,826 3,198 1.05    1,300 1,189 0.77 
Age*Gender HCCs
# 3,814 2,677 1.04    1,678 1,116 0.99 
#  Entitlement to an invalidity pension is confined to individuals aged 18 to 65.  
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Table 8:  Summary of predictive performance for models incorporating an LTC indicator – 
individual results and results for actual (non-truncated) expenditure quintiles, 
overall samples 
Risk Adjustment Model  MAPE R
2
adj. CPM    PR    
  [€]  [%]  [%]  Q-1 Q-2 Q-3 Q-4 Q-5
  Concurrent application 
N  788,130 
Mean expenditure  €  1,740 
Age*Gender*Invalidity  1,794  5.1  9.1  20.9 5.3 3.2 1.9 0.4 
Age*Gender*LTC  1,788  5.6  9.4  22.5 5.5 3.2 1.8 0.4 
Age*Gender  Invalidity*LTC  1,764  6.3  10.6 20.6 5.1 3.1 1.8 0.4 
Age*Gender*Invalidity*HOSP  1,226  24.6  37.9  9.3 2.4 1.5 1.2 0.8 
Age*Gender*LTC*HOSP  1,228  24.7  37.8  9.7 2.4 1.5 1.2 0.8 
Age*Gender  Invalidity*LTC  HOSP 1,329  22.9  32.6  6.8 1.6 1.5 1.4 0.8 
Reparameterised DCG/HCC: 





















































  Prospective application 
N  733,378  
Mean expenditure  €  1,762 
Age*Gender*Invalidity  1,862  4.6  8.3  20.7 5.5 3.3 1.9 0.4 
Age*Gender*LTC  1,864  4.7  8.2  22.1 5.7 3.3 1.8 0.4 
Age*Gender  Invalidity*LTC  1,841  5.4  9.3  20.4 5.4 3.2 1.9 0.4 
Age*Gender*Invalidity*HOSP  1,785  7.7  12.1 18.2 5.0 3.1 1.9 0.4 
Age*Gender*LTC*HOSP  1,788  7.7  11.9 19.2 5.2 3.1 1.8 0.4 
Age*Gender  Invalidity*LTC  HOSP 1,788  7.7  11.9 17.8 4.9 3.1 1.9 0.4 
Reparameterised DCG/HCC: 
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